argenx
ARGX
329 hedge funds and large institutions have $13.4B invested in argenx in 2024 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 126 increasing their positions, 117 reducing their positions, and 60 closing their positions.
5% more capital invested
Capital invested by funds: $12.7B → $13.4B (+$676M)
8% more repeat investments, than reductions
Existing positions increased: 126 | Existing positions reduced: 117
0.78% more ownership
Funds ownership: 56.53% → 57.31% (+0.78%)
5% less funds holding
Funds holding: 345 → 329 (-16)
9% less funds holding in top 10
Funds holding in top 10: 22 → 20 (-2)
14% less call options, than puts
Call options by funds: $90.7M | Put options by funds: $105M
25% less first-time investments, than exits
New positions opened: 45 | Existing positions closed: 60
Top Buyers
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$237M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$210M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
-$115M |
| 4 |
Millennium Management
New York
|
-$83.6M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$64.4M |
ARGX Hedge Fund Activity: Q1 2024 in Review
329 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in argenx (ARGX) for Q1 2024, worth a combined $13.4B — up 5.3% from $12.7B a quarter earlier.
Sellers outnumbered buyers: 60 funds closed out of ARGX and 45 opened new positions — a net loss of 15 holders — while 117 trimmed existing stakes and 126 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $709M. The largest seller was Morgan Stanley, cutting an estimated $237M.
- 329 institutional investors held argenx (ARGX) as of Q1 2024, down from 345 in Q4 2023.
- Funds reported $13.4B of argenx stock for Q1 2024, up 5.3% quarter-over-quarter.
- 45 funds opened new argenx positions in Q1 2024 and 60 closed out, a net change of -15 holders.
- The largest argenx buyer in Q1 2024 was T. Rowe Price Associates, an estimated $709M added.
- The largest argenx seller in Q1 2024 was Morgan Stanley, an estimated $237M sold.
Based on aggregated 13F filings for Q1 2024.